Literature DB >> 22674952

Juvenile idiopathic arthritis coexisting with sickle cell disease: two case reports.

Olufemi Adelowo1, Adebayo Samuel Edunjobi.   

Abstract

Two cases of coexisting juvenile idiopathic arthritis (JIA) and sickle cell disease (ages 7 and 17) are presented. The diagnoses of JIA were delayed for years because of the similarity of presentations in the two conditions. Both cases had been treated with non-steroidal anti-inflammatory drugs for years. Both had positive rheumatoid factor, and elevated erythrocyte sedimentation rate (ESR) while one of the patients had elevated serum ferritin and anticyclic citrullinated protein. Radiology showed marked arthritic changes with presence of avascular necrosis in a patient's head of femur. Both cases were treated with etanercept for 6 months each, as well as methotrexate. At the end of 6 months, the joint count for pains and swelling were done as well as ESR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22674952      PMCID: PMC3229412          DOI: 10.1136/bcr.10.2011.4889

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Juvenile idiopathic arthritis among Nigerians: a case study.

Authors:  Olufemi O Adelowo; A Umar
Journal:  Clin Rheumatol       Date:  2010-03-01       Impact factor: 2.980

2.  Co-existent sickle cell disease and juvenile rheumatoid arthritis. Two cases with delayed diagnosis and severe destructive arthropathy.

Authors:  K Nistala; K J Murray
Journal:  J Rheumatol       Date:  2001-09       Impact factor: 4.666

3.  Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases.

Authors:  M Michel; A Habibi; B Godeau; D Bachir; A Lahary; F Galacteros; A Fifi-Mah; S Arfi
Journal:  Semin Arthritis Rheum       Date:  2008-01-04       Impact factor: 5.532

  3 in total
  6 in total

1.  Juvenile polymyositis with unremitting pain and progressive loss of motor and bulbar function on a background of sickle cell disease.

Authors:  Shreya Bali; David D'Cruz; Marion Lazaro; Baba P D Inusa
Journal:  BMJ Case Rep       Date:  2015-03-27

Review 2.  Rheumatic Manifestations of Haemoglobinopathies.

Authors:  Michael Hughes
Journal:  Curr Rheumatol Rep       Date:  2018-08-14       Impact factor: 4.592

Review 3.  Therapeutic strategies for sickle cell disease: towards a multi-agent approach.

Authors:  Marilyn J Telen; Punam Malik; Gregory M Vercellotti
Journal:  Nat Rev Drug Discov       Date:  2019-02       Impact factor: 84.694

4.  Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis.

Authors:  Silvia R Brandalise; Rosemary Assis; Angelo B A Laranjeira; José Andrés Yunes; Pedro O de Campos-Lima
Journal:  Exp Hematol Oncol       Date:  2017-06-19

5.  Rheumatoid Arthritis in Sickle-Cell Population: Pathophysiologic Insights, Clinical Evaluation and Management.

Authors:  Isabel M McFarlane; David J Ozeri; Yair Saperstein; Milena Rodriguez Alvarez; Su Zhaz Leon; Kristaq Koci; Sophia Francis; Soberjot Singh; Moro Salifu
Journal:  Rheumatology (Sunnyvale)       Date:  2017-09-12

6.  Coexistent sickle-cell anemia and autoimmune disease in eight children: pitfalls and challenges.

Authors:  Valerie Li-Thiao-Te; Florence Uettwiller; Pierre Quartier; Florence Lacaille; Brigitte Bader-Meunier; Valentine Brousse; Mariane de Montalembert
Journal:  Pediatr Rheumatol Online J       Date:  2018-01-17       Impact factor: 3.054

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.